Jefferies Downgrades PAREXEL to Underperform from Buy

Symbols: PRXL
Share

Jefferies has downgraded PAREXEL to Underperform from Buy and lowered the price target to $19.50 from $29.


 
 
< Previous
JMP Securities Downgrades Allos Therapeutics to Market Perform from Outperform
Next >
UPDATE: Noble Downgrades Pharmasset to Hold
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Brain Trust